Product Description
Mechanisms of Action: XO Inhibitor
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: *
Approval Status: Not Approved
Approved Countries: India | Japan
Approved Indications: None
Known Adverse Events: None
Company: Fuji Yakuhin
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 2: Kidney Diseases|Gout|Diabetic Nephropathy
Phase 1: Gout
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|
| CTR20234213 | N/A |
Completed |
Gout |
2024-08-25 |
2025-04-29 |
Patient Enrollment|Primary Completion Date|Start Date|Study Completion Date|Treatments|Trial Status |
|
| CTR20240506 | N/A |
Completed |
Gout |
2024-06-07 |
2025-04-29 |
Patient Enrollment|Primary Completion Date|Start Date|Study Completion Date|Treatments|Trial Status |
|
| CTR20241016 | N/A |
Completed |
Gout |
2024-06-03 |
2025-05-25 |
Primary Completion Date|Start Date|Study Completion Date|Treatments|Trial Status |
|
| CTR20240507 | N/A |
Completed |
Gout |
2024-04-20 |
2025-04-29 |
Patient Enrollment|Primary Completion Date|Start Date|Study Completion Date|Treatments|Trial Status |
|
| CTR20234181 | N/A |
Completed |
Gout |
2024-02-18 |
2025-04-29 |
Patient Enrollment|Primary Completion Date|Start Date|Study Completion Date|Treatments|Trial Status |
|
| CTR20221820 | N/A |
Completed |
Gout |
2023-04-28 |
2025-04-29 |
Patient Enrollment|Primary Completion Date|Start Date|Study Completion Date|Treatments|Trial Status |
|
| CTR20230578 | N/A |
Completed |
Gout |
2023-04-07 |
2025-04-29 |
Patient Enrollment|Treatments |
|
| CTR20222404 | N/A |
Completed |
Gout |
2022-12-13 |
2025-04-29 |
Patient Enrollment|Primary Completion Date|Start Date|Study Completion Date|Treatments|Trial Status |
|
| CTR20212784 | N/A |
Completed |
Gout |
2022-06-28 |
2025-04-29 |
Patient Enrollment|Primary Completion Date|Start Date|Study Completion Date|Treatments|Trial Status |
|
| CTR20210653 | N/A |
Completed |
Gout |
2021-06-02 |
2025-04-29 |
Patient Enrollment|Primary Completion Date|Start Date|Study Completion Date|Treatments|Trial Status |
|
| CTR20211586 | N/A |
Completed |
Gout |
2019-09-20 |
2025-04-29 |
Primary Completion Date|Start Date|Study Completion Date|Treatments |
|
| JapicCTI-173783 | N/A |
Active |
Gout |
2019-03-31 |
|||
| CTR20253366 | N/A |
Not yet recruiting |
Gout |
None |
2025-08-23 |
||
| CTR20253087 | N/A |
Not yet recruiting |
Gout |
None |
2025-08-06 |
Treatments |
|
| CTR20191357 | N/A |
Not yet recruiting |
Gout |
None |
2025-04-29 |
Patient Enrollment|Treatments |
|
| CTR20220542 | N/A |
Recruiting |
Gout |
None |
2025-04-29 |
||
| CTR20202071 | N/A |
Recruiting |
Gout |
None |
2025-04-29 |
Patient Enrollment|Treatments |
|
| CTR20221610 | N/A |
Not yet recruiting |
Gout |
None |
2025-04-29 |
Treatments|Trial Status |
|
| CTR20202265 | P1 |
Completed |
Gout |
2020-12-17 |
2025-04-29 |
Patient Enrollment|Primary Completion Date|Start Date|Study Completion Date|Treatments|Trial Status |
|
| CTR20253654 | P1 |
Not yet recruiting |
Gout |
None |
2025-09-23 |
Treatments |
|
| UPWARD | P2 |
Completed |
Kidney Diseases|Diabetic Nephropathy |
2016-12-01 |
2019-03-20 |
Treatments |
|
| JapicCTI-111549 | P2 |
Completed |
Kidney Diseases |
None |
|||
| CTR20242688 | P2 |
Not yet recruiting |
Gout |
None |
2025-04-29 |
Treatments|Trial Status |
|
| JapicCTI-101316 | P2 |
Completed |
Gout |
None |
|||
| CTR20242693 | P2 |
Not yet recruiting |
Gout |
None |
2025-04-29 |
Patient Enrollment|Treatments|Trial Status |